Health and Underwriting
Life Insurance With Psoriasis: Get Fair Rates
You have psoriasis, or maybe psoriatic arthritis on top of it, and you are wondering whether that one word on your records will tank your life insurance. Usually it does not. Many people with mild, well-controlled psoriasis can still qualify for a carrier’s better pricing. The skin condition by itself is a minor factor to an underwriter. Psoriatic arthritis takes a closer look, because it reaches the joints and often involves stronger drugs, but it is still very much insurable.
Three things set your price far more than the diagnosis does: how much of your body is involved, which drug controls it, and whether the chart shows the disease steady. Two people with the same line on their records can land in very different places on those three.
What life insurance with psoriasis actually costs you
Start with body surface area. That is the share of your skin covered by plaques, and it is often written in the dermatologist’s notes as a percentage. Under roughly 3 percent is considered mild. Three to 10 percent is moderate. Above 10 percent is severe. Mild psoriasis managed with topical steroids, vitamin D creams, or occasional light therapy often moves your rate very little. Some carriers will still consider a well-controlled mild case with no other flags for their better pricing.
Second, the drug. A biologic like adalimumab, ustekinumab, or secukinumab, or an oral like methotrexate or apremilast, tells the underwriter the case was significant enough to need systemic treatment. Underwriters treat that as information, and it does not count against you by itself. A controlled case on a biologic usually reads better than an uncontrolled case on nothing, because control is exactly what carriers reward. This is the same logic running through almost every health condition, laid out in how life insurance underwriting works.
Third, stability over time. An underwriter wants to see the same picture across a couple of years: steady specialist visits, no jump to a stronger drug every few months, no recent hospital flare. A calm two-year stretch does more for your file than almost anything else.
How psoriatic arthritis changes the read
About 3 in 10 people with psoriasis also develop psoriatic arthritis, so if you have both, you are in common company. It changes the conversation because it reaches the joints and can, over years, cause lasting damage. Carriers want to know how far it has progressed, how much it limits your daily activity, and whether imaging or labs show it holding steady.
A mild case where you are active and working full time is usually a modest factor. An advanced case with documented joint erosion or frequent flares can bring a higher price than you hoped, often as a table rating rather than a flat decline. If that term is new, table ratings and flat extras walks through exactly what it does to your monthly cost.
The drugs overlap with those for severe psoriasis, so the same principle holds. The underwriter reads the medication as a marker of severity, then hunts for evidence it is working. A rheumatologist’s note describing controlled disease and stable inflammatory markers helps your case more than most applicants expect.
Two files, same diagnosis, different outcomes
Two applicants, both 47, both with psoriatic arthritis.
The first was diagnosed four years ago, takes one biologic she has not changed in three years, sees her rheumatologist every six months, and her notes describe stable joints with no flares in the past year. She works full time. A carrier that is comfortable with autoimmune conditions is likely to offer her a solid rate, possibly only a small step below the best available pricing.
The second was diagnosed eleven months ago and has switched medications twice while his doctor searches for the right fit. His notes mention ongoing joint pain and reduced mobility. His file is a wait-and-see. A carrier may offer coverage now at a higher price, or suggest reapplying once he has six to twelve months of stable records on one drug, because that steady stretch is what unlocks the better rate.
Same diagnosis, same age band, different results, and the gap is entirely about control and documentation. Neither applicant did anything wrong. One simply has a longer, calmer track record for the underwriter to read.
Three things that move your application
None of these require changing your treatment.
Get your records current. If your last specialist visit was more than a year ago, a recent check-in that describes your condition as stable gives the underwriter a fresh, favorable snapshot instead of a stale one. A note using the words controlled or stable is the single most useful line in your file.
List your diagnosis date and every medication accurately on the application. Many carriers pull prescription histories and medical records regardless, so leaving a drug off gains you nothing and risks a mismatch the insurer can question during the window, typically two years, after the policy issues. For how that window works, see the two-year contestability period.
Apply the fully underwritten way first. For most people with controlled psoriasis or psoriatic arthritis, a fully underwritten term life policy prices better than a no-questions option, because the exam and records let a good case speak for itself. If a single carrier comes back with a disappointing offer, treat it as one carrier’s opinion and keep looking. Autoimmune conditions are an area where carriers disagree sharply, and the right match changes the number. If you still want to understand the no-questions path, guaranteed issue vs simplified issue life insurance compares them plainly.
Starting your application the easy way
Psoriasis and psoriatic arthritis are conditions carriers see every week, and each has a clear pricing path. The work is matching your specific file, your body surface area, your drug, your stability, to the carrier most at ease with it.
Before you apply, pull together three details: your diagnosis date, the exact name of your current medication, and the specialist who treats you. With those in hand you can get a quote or call us at (888) 840-6183, and we can steer you toward the carriers that tend to look most kindly on autoimmune conditions. If you already hold a policy and your condition has stabilized or changed since you bought it, a policy review can tell you whether reapplying would now land you a better rate.
Ready to see real numbers?
Get a free, no-pressure quote from our licensed team. We work with the top carriers across the country to find the coverage that fits your situation.
Get Your Free Quote